574 related articles for article (PubMed ID: 27001391)
1. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
[TBL] [Abstract][Full Text] [Related]
2. Quantitative susceptibility mapping differentiates between parkinsonian disorders.
Sjöström H; Granberg T; Westman E; Svenningsson P
Parkinsonism Relat Disord; 2017 Nov; 44():51-57. PubMed ID: 28886909
[TBL] [Abstract][Full Text] [Related]
3. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
4. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
[TBL] [Abstract][Full Text] [Related]
5. Manual MRI morphometry in Parkinsonian syndromes.
Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders.
Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Kremser C; Wildauer M; Schocke M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
J Parkinsons Dis; 2019; 9(4):681-691. PubMed ID: 31450511
[TBL] [Abstract][Full Text] [Related]
7. Putaminal hyperintensity on T1-weighted MR imaging in patients with the Parkinson variant of multiple system atrophy.
Ito S; Shirai W; Hattori T
AJNR Am J Neuroradiol; 2009 Apr; 30(4):689-92. PubMed ID: 19147717
[TBL] [Abstract][Full Text] [Related]
8. Swallow tail sign on susceptibility map-weighted imaging (SMWI) for disease diagnosing and severity evaluating in parkinsonism.
Liu X; Wang N; Chen C; Wu PY; Piao S; Geng D; Li Y
Acta Radiol; 2021 Feb; 62(2):234-242. PubMed ID: 32380911
[TBL] [Abstract][Full Text] [Related]
9. Regional Selectivity of Neuromelanin Changes in the Substantia Nigra in Atypical Parkinsonism.
Chougar L; Arsovic E; Gaurav R; Biondetti E; Faucher A; Valabrègue R; Pyatigorskaya N; Dupont G; Lejeune FX; Cormier F; Corvol JC; Vidailhet M; Degos B; Grabli D; Lehéricy S
Mov Disord; 2022 Jun; 37(6):1245-1255. PubMed ID: 35347754
[TBL] [Abstract][Full Text] [Related]
10. Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy.
Constantinides VC; Paraskevas GP; Stamboulis E; Kapaki E
Neurol Sci; 2018 Feb; 39(2):359-364. PubMed ID: 29196955
[TBL] [Abstract][Full Text] [Related]
11. MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism.
Sugiyama A; Sato N; Kimura Y; Ota M; Maekawa T; Sone D; Enokizono M; Murata M; Matsuda H; Kuwabara S
Parkinsonism Relat Disord; 2018 Mar; 48():10-16. PubMed ID: 29279191
[TBL] [Abstract][Full Text] [Related]
12. Quantitative susceptibility mapping in atypical Parkinsonisms.
Mazzucchi S; Frosini D; Costagli M; Del Prete E; Donatelli G; Cecchi P; Migaleddu G; Bonuccelli U; Ceravolo R; Cosottini M
Neuroimage Clin; 2019; 24():101999. PubMed ID: 31539801
[TBL] [Abstract][Full Text] [Related]
13. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.
Tsukamoto K; Matsusue E; Kanasaki Y; Kakite S; Fujii S; Kaminou T; Ogawa T
Neuroradiology; 2012 Sep; 54(9):947-55. PubMed ID: 22274571
[TBL] [Abstract][Full Text] [Related]
14. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
[TBL] [Abstract][Full Text] [Related]
15. Characterization and diagnostic potential of R
Beliveau V; Müller C; Steiger R; Gizewski ER; Poewe W; Seppi K; Scherfler C
Parkinsonism Relat Disord; 2022 Aug; 101():43-48. PubMed ID: 35792337
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of 3D-PRESTO imaging in evaluating putaminal abnormality in parkinsonian variant of multiple system atrophy.
Sakurai K; Kawaguchi T; Kawai T; Ogino H; Hara M; Okita K; Yamawaki T; Shibamoto Y
Neuroradiology; 2010 Sep; 52(9):809-14. PubMed ID: 19894040
[TBL] [Abstract][Full Text] [Related]
17. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy.
Lee JH; Han YH; Kang BM; Mun CW; Lee SJ; Baik SK
J Neurol; 2013 Aug; 260(8):2094-101. PubMed ID: 23670309
[TBL] [Abstract][Full Text] [Related]
19. Automated Categorization of Parkinsonian Syndromes Using Magnetic Resonance Imaging in a Clinical Setting.
Chougar L; Faouzi J; Pyatigorskaya N; Yahia-Cherif L; Gaurav R; Biondetti E; Villotte M; Valabrègue R; Corvol JC; Brice A; Mariani LL; Cormier F; Vidailhet M; Dupont G; Piot I; Grabli D; Payan C; Colliot O; Degos B; Lehéricy S
Mov Disord; 2021 Feb; 36(2):460-470. PubMed ID: 33137232
[TBL] [Abstract][Full Text] [Related]
20. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.
Nicoletti G; Rizzo G; Barbagallo G; Tonon C; Condino F; Manners D; Messina D; Testa C; Arabia G; Gambardella A; Lodi R; Quattrone A
Radiology; 2013 Jun; 267(3):843-50. PubMed ID: 23329659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
